Claudia Regina Morris MD
Associate Professor, Pediatrics, Emory Univ Sch of Med
Join to View Full Profile
1405 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-785-7141
Fax+1 404-785-7989
Dr. Morris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital-OaklandResidency, Pediatrics, 1993 - 1996
Eastern Virginia Medical SchoolClass of 1993- UCSF Benioff Children’s Hospital OaklandFellowship, Pediatric Emergency Medicine (Pediatrics)
Certifications & Licensure
CA State Medical License 1994 - 2026
GA State Medical License 2012 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Emergency Medicine
Clinical Trials
- Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension Start of enrollment: 2009 Mar 01
- Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial Start of enrollment: 2000 Sep 01
- Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial Start of enrollment: 2021 Jun 21
Publications & Presentations
PubMed
- Development and Internal Validation of a Risk Assessment Tool to Identify Neonates at Risk for 60-Day Hospital Readmission in Dar es Salaam, Tanzania, and Monrovia, Li...Rodrick R Kisenge, Evance Godfrey, Readon C Ideh, Julia Kamara, Ye-Jeung Coleman-Nekar
The American Journal of Tropical Medicine and Hygiene. 2025-04-01 - Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers.Dunia Hatabah, Sneh Lata Gupta, Grace Mantus, Patrick Sullivan, Stacy Heilman
Vaccines. 2025-02-07 - Cobalamin Deficiency in Children and Adolescents with Sickle Cell Disease.Dunia Hatabah, Rachel Krieger, Lou Ann Brown, Frank Harris, Rawan Korman
Nutrients. 2025-02-06
Press Mentions
Emory and Children's Healthcare of Atlanta Now Part of Nationwide Pediatric Emergency Research Network (PECARN)September 17th, 2019
Sickle Cell Disease: No Longer the Road Less TravelledDecember 4th, 2018
Arginine Therapy May Hold New Promise for Sickle Cell PainSeptember 17th, 2013
Grant Support
- Patient-Oriented Research in Arginine Deficiency SyndromesEMORY UNIVERSITY2018–2028
- Patient-Oriented Research in Arginine Deficiency SyndromesEMORY UNIVERSITY2018–2028
- 1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)EMORY UNIVERSITY2020–2026
- Glutamine Therapy For Hemolysis-Associated Pulmonary HypertensionFood And Drug Administration2009–2011
- Nitric Oxide As A Marker For Degree Of Vaso-Occlusion In Sickle Cell DiseaseNational Center For Research Resources2005
- Arginine VOC TrialNational Center For Research Resources2005
- The Role Of Arginase Activity And Limited Arginine Bioavailability In AsthmaNational Center For Research Resources2004–2005
- Pneumonia NONational Center For Research Resources2004–2005
- Arginine/SsdNational Center For Research Resources2004–2005
- NO AsthmaNational Center For Research Resources2004
- Arginine Therapy In Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2000–2004
- Nitric Oxide As Marker For Degree Of VASO Occlusion In SCDNational Center For Research Resources2000–2002
- Arginine Therapy In Sickle Cell Disease: Pilot StudyNational Center For Research Resources2000–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
